Subscribe To

Price Alert Latest News Economic Calendar News

CHE / Chemtrade Logistics Income Fund (CGIFF) Q4 2022 Earnings Call Transcript

Chemtrade Logistics Income Fund (OTC:CGIFF) Q4 2022 Earnings Conference Call February 23, 2023 10:00 AM ET Company Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President & Chief Executive Officer Conference Call Participants Jacob Bout - CIBC Joel Jackson - BMO Capital Markets Steve Hansen - Raymond James Gary Ho - Desjardins Nelson Ng - RBC Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund Q4 2022 Annual Results Conference Call. At this time, all lines are in a listen-only mode. Read More

Demo Live Account See Partner Details

Content Topics

Chemtrade

Logistics

Income

Fund

Cgiff

2022

Earnings

Call

cgiff

Transcript

Stock

CHE

Posted: Feb 25 2023, 19:28

Author Name: Seeking Alpha

CHE News

By Zacks Investment Research
October 27, 2023

Chemed (CHE) Q3 Earnings and Revenues Surpass, Margins Rise

Chemed's (CHE) third-quarter 2023 performance reflects strength in the VITAS segment.

By Seeking Alpha
October 26, 2023

Chemed Corporation (CHE) Q3 2023 Earnings Call Transcript

Chemed Corporation (NYSE:CHE ) Q3 2023 Earnings Conference Call October 26, 2023 10:00 AM ET Company Participants Holley Schmidt - Assistant Controlle

By Zacks Investment Research
October 25, 2023

Chemed (CHE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Chemed (CHE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to com

By Zacks Investment Research
October 25, 2023

Chemed (CHE) Q3 Earnings and Revenues Beat Estimates

Chemed (CHE) came out with quarterly earnings of $5.32 per share, beating the Zacks Consensus Estimate of $4.92 per share. This compares to earnings o

By Zacks Investment Research
October 20, 2023

OPCH or CHE: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (

By InvestorPlace
September 25, 2023

3 Mighty Mid-Cap Stocks Ready to Shine This Fall

In the current market cycle, where inflation is sticky and central banks weigh their next move, some investors need help choosing which type of stocks

By Zacks Investment Research
September 18, 2023

DVA or CHE: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which o

By Zacks Investment Research
September 14, 2023

Chemed (CHE) Faces Macroeconomic Woes, Tough Competition

Inflationary trend, increased logistics costs and higher employee-related expenses continue to hurt Chemed's (CHE) growth.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.